首页 > 市场调查报告书 > 医疗设备

运输/物流生技设备

市场调查报告书

商品编码

1956184

日本医药低温运输物流市场规模、份额、趋势及预测（依产品、服务及地区划分，2026-2034年）

Japan Cold Chain Pharmaceutical Logistics Market Size, Share, Trends and Forecast by Product, Service, and Region, 2026-2034

出版日期: 2026年02月01日 | 出版商:

IMARC | 英文 142 Pages | 商品交期: 5-7个工作天内

价格

简介目录

2025年，日本医药低温运输物流市场规模达9.432亿美元。 IMARC集团预测，到2034年，该市场规模将达到21.933亿美元，2026年至2034年的复合年增长率（CAGR）为9.83%。日本製药公司生产种类繁多的温控药品，包括尖端生物製药和疫苗，因此可靠的低温运输物流对于确保这些药品的疗效和安全性至关重要。此外，物联网（IoT）的日益普及也推动了日本医药低温运输物流市场份额的扩大。

日本医药低温运输物流市场的发展趋势：

药品需求不断成长

药品需求的成长正对国内市场产生正面影响。随着人口老化和医疗意识的提高，越来越多的人需要严格控制温度的药物、疫苗和生物製药。根据日本政府预测，到2024年，65岁及以上人口将占总人口的约30%。日本製药公司生产种类繁多的对温度敏感的药品，包括创新型生物製药和疫苗，而可靠的低温运输物流对于维持这些药品的疗效和安全性至关重要。这些产品需求的不断增长推动了对先进冷藏设施、冷藏运输和监控系统的需求，以确保整个供应链的温度控制。医院、药局和诊所仍然高度依赖冷链物流来防止药品品质劣化。此外，日本政府的法规和品质标准要求严格遵守药品储存和运输规范，这使得物流公司能够投资更先进的技术和基础设施。药品进出口的成长也推动了市场发展，使得持续稳定的冷链管理对于国际运输至关重要。

物联网的日益普及

物联网的日益普及正在推动日本医药低温运输物流市场的成长。根据IMARC集团预测，到2024年，日本物联网市场规模预计将达到604.776亿美元。物联网技术能够即时监控药品储存和运输过程中的温度、湿度和位置，确保药品和疫苗保持在指定的温度范围内，防止劣化并保持其品质。一旦条件出现偏差，物联网设备会即时发出警报，以便及时采取纠正措施。这降低了产品损失的风险，并确保符合日本严格的监管标准。物联网还能提供准确的库存数量和有效期限信息，从而改善库存管理。物流公司正在利用物联网优化配送路线和时间安排，减少延误和成本。物联网的整合还提高了透明度和可追溯性，有助于在製药公司、医疗机构和患者之间建立信任。总而言之，物联网的日益普及满足了对安全及时交付温控医疗产品日益增长的需求，提高了日本医药低温运输物流的可靠性和效率。

本报告解答的关键问题

日本医药低温运输物流市场目前发展状况如何？未来几年又将如何发展？
日本药品低温运输物流市场依产品分類的组成是怎样的？
日本医药低温运输物流市场依服务类型分類的组成是怎样的？
日本医药低温运输物流市场按地区分類的市场组成是怎样的？
日本医药低温运输物流市场价值链的不同阶段有哪些？
日本医药低温运输物流市场的主要驱动因素与挑战是什么？
日本医药低温运输物流市场的结构是怎么样的？主要参与者有哪些？
日本医药低温运输物流市场竞争程度如何？

The Japan cold chain pharmaceutical logistics market size reached USD 943.2 Million in 2025 . Looking forward, IMARC Group expects the market to reach USD 2,193.3 Million by 2034, exhibiting a growth rate (CAGR) of 9.83% during 2026-2034. Pharmaceutical firms, based in Japan, are manufacturing a diverse range of temperature-sensitive medications, including cutting-edge biologics and vaccines, that necessitate dependable cold chain logistics to ensure their effectiveness and safety. Besides this, the rising utilization of the Internet of Things (IoT) is contributing to the expansion of the Japan cold chain pharmaceutical logistics market share.

JAPAN COLD CHAIN PHARMACEUTICAL LOGISTICS MARKET TRENDS:

Increasing demand for pharmaceutical products

Rising demand for pharmaceutical products is positively influencing the market in the country. As the population is aging and healthcare awareness is increasing, more people require medicines, vaccines, and biologics that need strict temperature control. As per the Japanese government authorities, individuals aged 65 and older in Japan represented almost 30% of the population in 2024. Pharmaceutical companies in Japan are producing a wide assortment of temperature-sensitive drugs, including innovative biologics and vaccines, which require reliable cold chain logistics to maintain their efficacy and safety. The increasing volume of these items is leading to higher demand for advanced cold storage facilities, refrigerated transportation, and monitoring systems that ensure proper temperature management throughout the supply chain. Hospitals, pharmacies, and clinics continue to rely heavily on cold chain logistics to receive medicines without degradation. Furthermore, government regulations and quality standards in Japan require stringent compliance in pharmaceutical storage and transport, which is enabling logistics providers to invest in better technology and infrastructure. The rise in export and import of pharmaceutical products is also stimulating the growth of the market, as international shipments demand consistent cold chain management.

Growing utilization of IoT

Rising use of the IoT is impelling the Japan cold chain pharmaceutical logistics market growth. According to the IMARC Group, the Japan IoT market size reached USD 60,477.6 Million in 2024. IoT technology allows real-time monitoring of temperature, humidity, and location of pharmaceutical products during storage and transportation. This ensures that medicines and vaccines remain within the required temperature range, preventing spoilage and maintaining their quality. IoT devices send instant alerts if there is any deviation in conditions, allowing quick corrective actions. This reduces the risk of product loss and ensures compliance with strict regulatory standards in Japan. Additionally, IoT improves inventory management by offering precise information on stock quantities and expiration dates. Logistics companies are using IoT to optimize routes and delivery schedules, reducing delays and costs. The integration of IoT also increases transparency and traceability, building trust among pharmaceutical companies, healthcare providers, and patients. Overall, rising IoT adoption enhances the reliability and effectiveness of cold chain pharmaceutical logistics in Japan, supporting the growing demand for safe and timely delivery of temperature-sensitive medical products.

JAPAN COLD CHAIN PHARMACEUTICAL LOGISTICS MARKET SEGMENTATION:

Product Insights:

Vaccines
Biopharmaceuticals
Clinical Trial Materials

Service Insights:

Warehousing and VAS
Transportation

Regional Insights:

Kanto Region
Kansai/Kinki Region
Central/ Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

KEY QUESTIONS ANSWERED IN THIS REPORT

How has the Japan cold chain pharmaceutical logistics market performed so far and how will it perform in the coming years?
What is the breakup of the Japan cold chain pharmaceutical logistics market on the basis of product?
What is the breakup of the Japan cold chain pharmaceutical logistics market on the basis of service?
What is the breakup of the Japan cold chain pharmaceutical logistics market on the basis of region?
What are the various stages in the value chain of the Japan cold chain pharmaceutical logistics market?
What are the key driving factors and challenges in the Japan cold chain pharmaceutical logistics market?
What is the structure of the Japan cold chain pharmaceutical logistics market and who are the key players?
What is the degree of competition in the Japan cold chain pharmaceutical logistics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Cold Chain Pharmaceutical Logistics Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Cold Chain Pharmaceutical Logistics Market Landscape

5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)

6 Japan Cold Chain Pharmaceutical Logistics Market - Breakup by Product

6.1 Vaccines
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2020-2025)
- 6.1.3 Market Forecast (2026-2034)
6.2 Biopharmaceuticals
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2020-2025)
- 6.2.3 Market Forecast (2026-2034)
6.3 Clinical Trial Materials
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2020-2025)
- 6.3.3 Market Forecast (2026-2034)

7 Japan Cold Chain Pharmaceutical Logistics Market - Breakup by Service

7.1 Warehousing and VAS
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2020-2025)
- 7.1.3 Market Forecast (2026-2034)
7.2 Transportation
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2020-2025)
- 7.2.3 Market Forecast (2026-2034)

8 Japan Cold Chain Pharmaceutical Logistics Market - Breakup by Region

8.1 Kanto Region
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2020-2025)
- 8.1.3 Market Breakup by Product
- 8.1.4 Market Breakup by Service
- 8.1.5 Key Players
- 8.1.6 Market Forecast (2026-2034)
8.2 Kansai/Kinki Region
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2020-2025)
- 8.2.3 Market Breakup by Product
- 8.2.4 Market Breakup by Service
- 8.2.5 Key Players
- 8.2.6 Market Forecast (2026-2034)
8.3 Central/ Chubu Region
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2020-2025)
- 8.3.3 Market Breakup by Product
- 8.3.4 Market Breakup by Service
- 8.3.5 Key Players
- 8.3.6 Market Forecast (2026-2034)
8.4 Kyushu-Okinawa Region
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2020-2025)
- 8.4.3 Market Breakup by Product
- 8.4.4 Market Breakup by Service
- 8.4.5 Key Players
- 8.4.6 Market Forecast (2026-2034)
8.5 Tohoku Region
- 8.5.1 Overview
- 8.5.2 Historical and Current Market Trends (2020-2025)
- 8.5.3 Market Breakup by Product
- 8.5.4 Market Breakup by Service
- 8.5.5 Key Players
- 8.5.6 Market Forecast (2026-2034)
8.6 Chugoku Region
- 8.6.1 Overview
- 8.6.2 Historical and Current Market Trends (2020-2025)
- 8.6.3 Market Breakup by Product
- 8.6.4 Market Breakup by Service
- 8.6.5 Key Players
- 8.6.6 Market Forecast (2026-2034)
8.7 Hokkaido Region
- 8.7.1 Overview
- 8.7.2 Historical and Current Market Trends (2020-2025)
- 8.7.3 Market Breakup by Product
- 8.7.4 Market Breakup by Service
- 8.7.5 Key Players
- 8.7.6 Market Forecast (2026-2034)
8.8 Shikoku Region
- 8.8.1 Overview
- 8.8.2 Historical and Current Market Trends (2020-2025)
- 8.8.3 Market Breakup by Product
- 8.8.4 Market Breakup by Service
- 8.8.5 Key Players
- 8.8.6 Market Forecast (2026-2034)

9 Japan Cold Chain Pharmaceutical Logistics Market - Competitive Landscape

9.1 Overview
9.2 Market Structure
9.3 Market Player Positioning
9.4 Top Winning Strategies
9.5 Competitive Dashboard
9.6 Company Evaluation Quadrant

10 Profiles of Key Players

10.1 Company A
- 10.1.1 Business Overview
- 10.1.2 Services Offered
- 10.1.3 Business Strategies
- 10.1.4 SWOT Analysis
- 10.1.5 Major News and Events
10.2 Company B
- 10.2.1 Business Overview
- 10.2.2 Services Offered
- 10.2.3 Business Strategies
- 10.2.4 SWOT Analysis
- 10.2.5 Major News and Events
10.3 Company C
- 10.3.1 Business Overview
- 10.3.2 Services Offered
- 10.3.3 Business Strategies
- 10.3.4 SWOT Analysis
- 10.3.5 Major News and Events
10.4 Company D
- 10.4.1 Business Overview
- 10.4.2 Services Offered
- 10.4.3 Business Strategies
- 10.4.4 SWOT Analysis
- 10.4.5 Major News and Events
10.5 Company E
- 10.5.1 Business Overview
- 10.5.2 Services Offered
- 10.5.3 Business Strategies
- 10.5.4 SWOT Analysis
- 10.5.5 Major News and Events

11 Japan Cold Chain Pharmaceutical Logistics Market - Industry Analysis

11.1 Drivers, Restraints, and Opportunities
- 11.1.1 Overview
- 11.1.2 Drivers
- 11.1.3 Restraints
- 11.1.4 Opportunities
11.2 Porters Five Forces Analysis
- 11.2.1 Overview
- 11.2.2 Bargaining Power of Buyers
- 11.2.3 Bargaining Power of Suppliers
- 11.2.4 Degree of Competition
- 11.2.5 Threat of New Entrants
- 11.2.6 Threat of Substitutes
11.3 Value Chain Analysis

12 Appendix

02-2729-4219

+886-2-2729-4219

License/价格

日本医药低温运输物流市场规模、份额、趋势及预测（依产品、服务及地区划分，2026-2034年）

Japan Cold Chain Pharmaceutical Logistics Market Size, Share, Trends and Forecast by Product, Service, and Region, 2026-2034

日本医药低温运输物流市场的发展趋势：

本报告解答的关键问题

目录

第一章：序言

第二章：调查范围与调查方法

第三章执行摘要

第四章：日本医药低温运输物流市场概况

第五章：日本医药低温运输物流市场概况

第六章：日本药品低温运输物流市场：依产品细分

第七章：日本医药低温运输物流市场－依服务类型细分

第八章：日本医药低温运输物流市场：依地区划分

第九章：日本医药低温运输物流市场：竞争格局

第十章主要企业概况

第十一章：日本医药低温运输物流市场：产业分析

第十二章附录